Semaglutide 5 mg vials (powder for reconstitution)

Semaglutide 5 mg vials (powder for reconstitution)

Misc (Generics)

Prescription-only medicine (POM)
    GLP\u20111 receptor agonist; injectable semaglutide \u2014 compounded/unapproved vial (non\u2011commercial)

    Description

    Semaglutide is a GLP‑1 receptor agonist — active ingredient in authorised medications for type 2 diabetes and obesity (e.g. , ). The vials described (5 mg powder for reconstitution plus bacteriostatic water, syringes, alcohol pads) do not correspond to any regulatory‑approved product presentation, and appear to be offered for injection use. Such unapproved/unlicensed products are subject to regulatory warnings and safety risks. :contentReference[oaicite:2]{index=2}

    Bnefits

    Not publicly listed

    Indications

    Not publicly listed

    Composition

    • Semaglutide (peptide), powder form (for reconstitution)

    Formulation

    • Lyophilised powder for subcutaneous injection (after reconstitution)

    Packaging

    • Vials containing semaglutide powder (5 mg), bacteriostatic water vials, 1 mL / 100 IU syringes, alcohol pads — as per vendor listing

    Usage

    • User-supplied reconstitution with bacteriostatic water before administration (per vendor directions — not an official SmPC)

    Contraindications

    Not publicly listed

    Adverse Effects

    Not publicly listed

    Storage Conditions

    Not publicly listed

    Duration

    Onset

    Browse more Prescription-only medicine (POM)

    Top Treatments

    Top Cities in the UK